​

Aprea Therapeutics (APRE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aprea Therapeutics Revenue Highlights

00

Aprea Therapeutics Revenue by Period

Aprea Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$583.23K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Aprea Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aprea Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31-100.00%
2024-09-30--100.00%
2024-06-30$561.57K47.56%
2024-03-31$380.57K2603.87%
2023-12-31$14.07K-95.59%
2023-09-30$319.47K27.95%
2023-06-30$249.69K100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Aprea Therapeutics generated - in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Aprea Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ANABAnaptysBio$91.28M$43.11M
GBIOGeneration Bio$19.89M$4.19M
ADAGAdagene$18.11M$833.34K
SRZNSurrozen$10.65M$655.00K
APMAptorum Group$431.38K-
SILOSilo Pharma$72.10K$18.03K
RNXTRenovoRx$43.00K$197.00K
IKNAIkena Oncology--
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
APREAprea Therapeutics--
FBRXForte Biosciences--
MLYSMineralys Therapeutics--
UNCYUnicycive Therapeutics--
TPSTTempest Therapeutics-$486.00K
ACRVAcrivon Therapeutics--

APRE Revenue FAQ

What is Aprea Therapeutics’s yearly revenue?

Aprea Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $583.23K, representing an increase of 100.00% compared to 2022. APRE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Aprea Therapeutics’s quarterly revenue?

Aprea Therapeutics's quarterly revenue for Q4 2024 was $0, a 100.00% increase from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). APRE's quarterly revenue for Q2 2024 was $561.57K, a 47.56% increase from the previous quarter (Q1 2024), and a 124.91% increase year-over-year (Q2 2023).

What is Aprea Therapeutics’s revenue growth rate?

Aprea Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.